Erratum. In the article "Fractionation of Phytohemagglutinin, I. Purification of the RNA and DNA Synthesis-Stimulating Substances and Evidence That They Are Not Proteins," by M. L. Goldberg, W. Rosenau, and G. C. Burke, which appeared in the September 1969 issue of Proc. Nat. Acad. Sci. USA, 64, 283-289, a quotient line was omitted from the asterisked footnote to Table 1 , which should read: *Activity/ml =(nmoles incorporated into test fraction -nmoles incorporated into saline control).
volume assayed
In addition, line 4 on p. 287 should be deleted, and the last two paragraphs of text on p. 289 should be preceded by Note Added in Proof.
Erratum. In the article "A Study on the Transcription of the Polyoma Viral Genome," by J. Hudson, D. Goldstein, and R. Weil, which appeared in the January 1970 issue of Proc. Nat. Acad. Sci. USA, 65, 226-233, the following corrections should be made. In the Introduction (p. 226), line 4, "application" should read "replication," in Results (p. 230), last line, "formal" should read "normal," and in the Discussion (p. 232), line 2 All other chemicals were of reagent grade.
Assay for protein: Protein was assayed by the biuret procedure scaled down to micro size.9 When necessary, the protein was concentrated for assay by the method of Bennett. 10 Assay for carbohydrate: Total carbohydrate (except for amino sugars) was assayed by the indole method." Values are expressed as micrograms of glucose.
Assay for stimulation of RNA synthesis: A suspension of leukocytes containing approximately 80% lymphocytes was obtained from fresh pig blood. The method of Coulson and Chalmers'2 was used, except that the cells were allowed to settle for 1 hr instead of 30 min. The cells were suspended in autologous serum at a concentration of 3-6 X 106 lymphocytes/ml. This suspension was then diluted with 2 vol of medium 199 and used immediately. The assay mixture contained 1.6 ml of dilute lymphocyte suspension, 0.2 ml of uridine-5-'H (2 X 10-i M, 50 Ci/M) and the fraction to be assayed (usually 0.02 ml). The mixture was brought to a final vol of 2.0 ml with PM buffer (potassium phosphate, pH 7.5, 5 X 10-' M and magnesium chloride, 5 X 10-' M). The assay mixture was incubated in 15 X 125-mm culture tubes in an atmosphere of air with 5% CO2
at 37' for 20 hr. Then the tubes were chilled in ice, the cells were scraped from the walls of the tubes, suspended in 4 ml of ice-cold buffered saline (potassium-sodium phosphate, pH 7.5, 0.075 AI; sodium chloride, 0.075 M) and centrifuged in the cold at 2000 X g for 5 min. The cell button was washed once in buffered saline, the supernatant solution was discarded, and the cells were evenly suspended in the small amount of fluid remaining in the tube. We added 0.1 ml of ice-cold 10% trichloroacetic acid (TCA) to the suspension, mixed the precipitate until it was quite smooth, and added 5 ml of ice-cold 5%
TCA. After standing for 7 min at 40C, the precipitate was collected by vacuum filtration on glass fiber filters (Whatman GF/C). After thorough washing with cold 5% TCA, the filters were placed into counting vials and dried at 650C. The filters were treated at room temperature for 20 min with 0.5 ml of concentrated formic acid; then 10 ml of scintillation counting fluid (667 ml of toluene, 333 ml of 2-methoxy-ethanol, 5 gm 2,5-bis-[2-(5-t-butylbenzoxazolyl) ]-thiophene was added. The radioactivity was measured in a Beckman LS-100 liquid scintillation counter with an efficiency of 17%. Each determination was carried out in duplicate. In comparative assays, all fractions were tested at the same time with the same batch of lymphocytes. This assay, as well as the assay for DNA synthesis, shows a linear proportionality, in the range used (0-0.03 ml of a fraction), between the amount of material assayed and the synthesis of nucleic acid. With 0.04 ml of material, the stimulus reaches a plateau, which it maintains up to the largest amount assayed, 0.8 ml. Commercial phytohemagglutinin (Difco, PHA-P) shows a sharp peak of activity with rapidly declining nucleic acid synthesis with the addition of more material. Microscopically, our fraction IV shows no toxicity in the assay mixtures, while toxicity is evident if the commercial phytohemagglutinin is used. The results of duplicate assays for RSS activity agree within better than 3%, while those for the DSS activity assay agree within 6%. Microscopic observations of blast formation and mitosis correlate well with the chemical assays.
Assay for stimulation of DNA synthesis: The assay of DNA synthetic activity followed exactly the same steps as described for RNA synthetic activity except that (1) thymidine-6-8H (1 X 10-2 Al, 60 Ci/M) was used in place of the radioactive uridine, and (2) the time of incubation was extended to 48 hr.
Assay for leukoagglutinating activity: BALB/c mouse lymphocytes were prepared from mouse spleen cells following the method of Janowsky et al., 3 except that centrifugation in plastic tubes was omitted. The cells were suspended in saline at a concentration of 2-5 X 107 cells/ml. Serial dilutions (0.1 ml) of the fraction to be tested (or buffer, as a control)
were mixed with the lymphocyte suspension (0.1 ml) and incubated at 370C for 1 hr in 12 X 75-mm culture tubes. The tubes, centrifuged at 450 X g for 5 min at room tempera-ture, were drained and then gently shaken. The cell suspensions, poured onto slides, were examined microscopically.
Assay for erythroagglutinating activity: The assay follows the technique of Sever,'4 except that 0.1 ml of RBC suspension and 0.1 ml of test fraction were used.
Purification of RSS activities and DSS activities: All procedures were carried out at 0-40C unless stated otherwise.
Extraction of beans and first ethanol fractionation: Dry kidney beans (Phaseolus vulgaris) were ground at room temperature and the powder was passed through a 20-mesh sieve. A kilogram of the powder was stirred for 24 hr with 4000 ml of 0.02 M potassium phosphate (pH 6.8) containing 0.1 M NaCl. The supernatant solution was heated to 800C for 10 min, and the resulting precipitate was discarded; the supernatant solution was cooled to 20C; ice-cold ethanol was added slowly until the ethanol concentration reached 30%. The resulting precipitate was removed by centrifugation and discarded. The ethanol concentration was then raised to 65% and the precipitate was collected by centrifugation, washed with absolute ethanol and then with ether, and air-dried at room temperature. The resulting powder could be stored for months at -70'C. The procedure up to this point followed essentially a method of Bdrjeson.'5 The powder was thoroughly stirred with PM buffer. The cloudy suspension was centrifuged at 10,000 X g for 30 min and the supernatant solution passed through a Millipore filter (GS type, pore size 0.22 1a). This filtrate was called fraction I.
Perchloric acid fractionation: Ice-cold perchloric acid (11.5 M) was added to fraction I to a final concentration of 1.6 M. After standing for 20 min, the precipitate was removed by centrifugation at 15,000 X g for 20 min. The supernatant solution was adjusted to pH 7.4-7.7 with potassium hydroxide (8 M) . The solution stood 20 min at 40C and the salt was removed by filtration (Schleicher and Schuell, SS605 filter paper). The filtrate was kept in the cold overnight and the supernatant solution decanted from the newly formed precipitate. This supernatant solution was designated fraction II.
Ethanol fractionation (0-30%): Fraction II was brought to an ethanol concentration of 30% (the temperature within the mixture must not be allowed to rise above 20), the material precipitating within 30 min was collected by centrifugation at 15,000 X g for 40 min, and the residual ethanol was evaporated from it by passing nitrogen over it.
The material must be taken up in a volume of PM buffer equal to that used to dissolve the aliquot of fraction I. This solution was called fraction III. Treatment by Sevag's method: Fraction III was treated by the following slight modification of Sevag's method:"6 Equal volumes of fraction III and of chloroform-isoamyl alcohol (24:1 by vol) were mechanically shaken very vigorously in the cold for 30 min.
After shaking, the resulting emulsion was centrifuged for 1 min at 1000 X g at room temperature. The aqueous portion was retreated with chloroform-isoamyl alcohol as described until the interface was almost invisible, which, depending on the volume, will take from 10 to 25 cycles. The aqueous extract was then thoroughly dialyzed against PM buffer. This dialyzed solution was called fraction IV. Treatment with proteolytic enzymes: Fraction IV (10 ml), after dialysis against Tris-Cl, hr, 30 mg of trypsin were added. At 72 hr, concentrated perchloric acid was added (final concentration 1.6 AM). The precipitate was removed by centrifugation and the supernatant solution was neutralized with potassium hydroxide. The salt was removed by centrifugation and the supernatant solution was dialyzed against PM buffer.
Activity of the proteolytic enzymes was demonstrated by observing a steady rise in amount of ninhydrin reactive material in aliquots of the reaction mixture. The controls contained water instead of the enzyme solutions.
RNase and DNase treatment: Fraction IV (5 ml) was incubated with 0.1 ml of pan-creatic RNase (615 Mtg/ml) at 370C for 2 hr. The enzyme was removed by 3 cycles of Sevag's procedure and the solution was thoroughly dialyzed against PM buffer.
Fraction IV (5 ml) was incubated with 0.2 ml of DNase (96 ,ug/ml), 0.05 ml calcium chloride (0.01 M) at room temperature for 5 and 24 hr. The enzyme was removed and the solution dialyzed as above. Fraction IV was lyophilized and then dissolved in sodium succinate, pH 6.5, 0.25 M, containing one unit of spleen phosphodiesterase per ml. The mixture was incubated for 20 hr at 37°. Lyophilized fraction IV was dissolved in a solution containing Tris-Cl, pH 8.8, 0.1 M; MgCl2, 0.3 M, and 1Oug/ml of snake venom phosphodiesterase. The mixture was incubated at 250 for 24 hr. In both cases the enzyme was removed and the solution dialyzed as described above.
Periodate treatment: Aliquots of fraction IV (9 ml) were treated with 1 ml of sodium periodate (concentrations ranging from 0.05 to 0.25 Al) at room temperature for 10-120 min. The reaction was terminated by addition of glycerol (10 X molar excess), and the solution was thoroughly dialyzed against PM buffer. Zero time controls were prepared by mixing glycerol and periodate and then adding fraction IV after 30 min.
Effect of plant hormones on lymphocyte RNA and DNA synthesis: In order to determine if the RSS activities and DSS activities in our preparations are due to known plant hormones, we added the following to our test systems and measured RNA and DNA synthesis of lymphocytes. The final concentrations were: kinetin, 2 X 10-s M; benzyl adenine, 5 X 10-7 M, 1 X 10-5 M; kinetin riboside, 1 X 10-5 M and 1 X 10-4 M; gibberellic acid, 1.5 X 10--M; indoleacetic acid, 6 X 10 -M; kinetin, 1 X 10-5 M plus indoleacetic acid, 3 X 10-5 M; kinetin riboside, 1 X 10-5 M plus indoleacetic acid, 3 X 10-" M; kinetin riboside, 1 X 10-4 M plus indoleacetic acid, 5 X 10-5 M; gibberellic acid, 7.5 X 10-4 M plus indoleacetic acid, 3 X 10-s M.
Results.-There was no corresponding loss of the RSS and DSS activities upon progressive deproteinization of the extract of Phaseolus vulgaris. If we compare fraction I and fraction IV in a typical experiment (Table 1) , we observe that less than 0.2 per cent of the protein per ml remains in fraction IV but that there is only a 25 per cent loss of the RSS and a 12 per cent loss of the DSS. It is noteworthy that treatment with perchloric acid did not destroy the RSS or DSS activities. Likewise there was no loss per ml of solution with Sevag's procedure, although there was an inevitable loss in volume, and thus in total activity. Erythroagglutinin and leukoagglutinin activity, present at high titer in fraction I, were present at a much lower titer in fraction III, and were absent from fraction IV after Sevag's treatment. * Activity/ml = (nmoles incorporated into test fraction -nmoles incorporated into saline control).
The activity of saline controls was always less than 5% of that of the experimental preparations.
Treatment of fraction IV with periodate resulted in a disproportionately greater loss of the DSS than the RSS activity. In a typical experiment, when this fraction was treated with 0.005 M periodate for 60 minutes, 25 per cent of the results of duplicate assays for RSS activity agree within better than 3%, while original RSS activity but only 6 per cent of the DSS activity remained (Fig. 1) . To determine if the decreasing RSS and DSS activities were due to a toxic product produced by periodate, we compared the survival of lymphocytes by dye exclusion test in cultures treated with fraction IV and with fraction IV exposed to periodate; the per cent survival was similar.
Pronase (Table 2) , trypsin, DNase (Table 2) , RNase (Table 2) , snake venom and spleen phosphodiesterase have no effect on RSS and DSS activities. Neither activity in fraction IV is lost by dialysis or by incubation with 8 M urea. Fraction IV has been stored for up to six months at -70oC without loss of activity. Both activities are destroyed by exposure to acid in fraction IV, although they are not affected significantly by acid in the crude state.
Fraction IV has a peak absorbance at 273 nm, differing clearly from a 280-nm protein peak. This fraction reacts strongly with the Folin-phenol reagent; however, it should be noted that many plant products contain phenolic compounds.
Treatment of lymphocytes with cytokinetins, gibberellic acid and auxin, alone or in combination, did not result in stimulation of RNA or DNA synthesis, indicating that the observed stimulation by our preparations from Phaseolus vulgaris was not due to these plant hormones.
Discussion. We believe that the true molecular weight of the active substances can only be determined after further purification. We suggest that these activities may be mediated by small molecular-weight substances which become adsorbed to proteins, explaining their presence in the protein fractions obtained by others.3 5 The word phytohemagglutinin should be abandoned, since it is used sometimes to refer only to an erythro-agglutinating activity, at other times to both erythroand leuko-agglutinating activity, or to the mitogenic principle alone, or, finally, to several types of bean extracts, which include crude extracts, different commercial products, or an apparently homogeneous protein obtained by Rigas and Johnson.5 Similarly, the word lectin is inappropriate as an alternative to phytohemagglutinin, since again it refers to the agglutinating property of the extract and also implies that there is one substance. We propose that the terms phyto-
